Systematic Review of the Economic Evaluation of Sodium–Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure Kyungae NamDaniel Sung-Ho ChoSun-Kyeong Park Systematic Review 26 June 2023 Pages: 463 - 474
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review Katharina Karsten DafonteLisa WeberMartin Coenen Systematic Review Open access 18 July 2023 Pages: 475 - 502
Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials Fangfang WangZhiping LiuHaiyan Li Original Research Article 28 June 2023 Pages: 503 - 515
Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation Pedro Herranz-PintoMaria Luisa Alonso-PachecoAlicia Herrero-Ambrosio Original Research Article Open access 04 July 2023 Pages: 517 - 527
Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden Nahila JustoNils WilkingLinus Jönsson Original Research Article Open access 08 July 2023 Pages: 529 - 540
Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort Yonghwan KimSang-Jun ShinHee-Taik Kang Original Research Article 17 July 2023 Pages: 541 - 550
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis Mark T. BrownDavid R. CornblathChristine R. West Original Research Article 18 July 2023 Pages: 551 - 563
Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients Shubhadeep D. SinhaAvula RajammaSrinivas Reddy Devireddy Original Research Article 18 July 2023 Pages: 565 - 574
Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial Amber van BroekhovenJohn W. Eikelboomthe LoDoCo2 investigators Research Letter 20 July 2023 Pages: 575 - 577